Back to Trades
Exton Michael
Chief Executive OfficerDirectorCIK 0002029249
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Exton Michael, Chief Executive Officer, Director, has disclosed $301.1K in transactions — all concentrated in LEXICON PHARMACEUTICALS, INC. (LXRX). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Mar 3 | LXRX LEXICON PHARMACEUTICALS, INC. | Exton Michael | Chief Executive Officer, Director | Exercise | $301.1K |
1 filing